Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel. NK Arora, chairperson of the Centre's Covid Working Group, has said that the vaccine is entering Phase 3 trials and could be available by October.